Miniaturized Bio-and Chemical-Sensors for Point-of-Care Monitoring of Chronic Kidney Diseases.

Existing Reviews

Please note, new claims can take a short while to show up.

No claims yet.

Annotation Summary

Term Occurence Count Dictionary
chronic kidney disease 3 nephrologydiseases
kidney failure 1 nephrologydiseases

There are not enough annotations found in this document to create the proximity graph.

Review

Having read the paper, please pick a pair of statements from the paper to indicate that a drug and disease are related.

Select Drug Character Offset Drug Term Instance
Select Disease Character Offset Disease Term Instance
chronic kidney disease 623 (POC) sensor technologies for the monitoring of ammonia, creatinine and urea in patients suffering of chronic kidney disease s (CKDs). Abnormal levels of these nitrogen biomarkers are found in the physiological fluids, such as
chronic kidney disease 5140 large fraction of the world population [[9]]. Patients with end stage renal disease, i.e., suffering of chronic kidney disease (CKD), have limited mobility, and must go to the hospital for diagnosis and care. The determination
chronic kidney disease 24413 is only mildly impaired [[54]]. Exhaled volatile substances mirror clinical conditions in pediatric chronic kidney disease [[55]]. However, progress in the use of breath analysis for the diagnostics and treatment monitor in
kidney failure 23826 potential to contribute to improve the quality of life of CKD patients by early-stage diagnosis of kidney failure and monitoring of hemodialysis treatment progress and frequency [[51]]. Since Simenhoff et al. found

You must be authorized to submit a review.